背景(考古学)
药理学
药品
化学
医学
生物
古生物学
作者
Kevin A. Scott,Munaum H. Qureshi,Philip B. Cox,Christopher M. Marshall,Bailey C. Bellaire,M Wilcox,Bradey A. R. Stuart,Jón T. Njardarson
标识
DOI:10.1021/acs.jmedchem.0c01502
摘要
The FDA Green Book is a list of all drug products that have been approved by the FDA for use in veterinary medicine. The Green Book, as published, lacks structural information corresponding to approved drugs. To address this gap, we have compiled the structural data for all FDA Green Book drugs approved through the end of 2019. Herein we discuss the relevance of this data set to human drugs in the context of structural classes and physicochemical properties. Analysis reveals that physicochemical properties are highly optimized and consistent with a high probability of favorable drug metabolism and pharmacokinetic properties, including good oral bioavailability for most compounds. We provide a detailed analysis of this data set organized on the basis of structure and function. Slightly over half (51%) of vet drugs are also approved in human medicine. Combination drugs are biologics are also discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI